Edgewise Therapeutics, Inc. (EWTX) has 14 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 17, 2026 filed Aug. 12, 2026 | Nofi Michael Chief Financial Officer | $0 | 48,750 | 0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 12, 2026 | Donovan Joanne M. CMO | $0 | 65,000 | 0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 12, 2026 | Russell Alan J Chief Scientific Officer | $0 | 65,000 | 0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 12, 2026 | Derakhshan Behrad Chief Business Officer | $0 | 100,000 | 0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 12, 2026 | MOORE JOHN R General Counsel | $0 | 65,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free